IBDR:NYE-iShares iBonds Dec 2026 Term Corporate ETF (USD)

ETF | Target Maturity |

Last Closing

USD 24.13

Change

-0.02 (-0.08)%

Market Cap

USD 2.88B

Volume

0.77M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its assets in the component instruments of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index consists of U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Target Maturity

Symbol Name Price(Change) Market Cap
IBDQ iShares iBonds Dec 2025 Term C..

-0.01 (-0.04%)

USD 2.78B
IBDS iShares iBonds Dec 2027 Term C..

-0.03 (-0.12%)

USD 2.57B
IBDT iShares iBonds Dec 2028 Term C..

-0.05 (-0.20%)

USD 2.24B
IBDP iShares iBonds Dec 2024 Term C..

N/A

N/A

ETFs Containing IBDR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Target Maturity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.96% 100% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.96% 100% F 35% F
Trailing 12 Months  
Capital Gain 3.21% 60% D- 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.21% 60% D- 28% F
Trailing 5 Years  
Capital Gain -5.29% 100% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.29% 100% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.88B 100% F 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike